Cargando…

Implementing a 3As and ‘Opt-Out’ Tobacco Cessation Framework in an Outpatient Oncology Setting

Tobacco cessation has been recognized as an important goal for all ambulatory cancer centres to provide the best possible treatment outcomes and quality of life. However, cessation interventions are applied inconsistently in this setting, with less than one-half of tobacco users being offered eviden...

Descripción completa

Detalles Bibliográficos
Autores principales: Himelfarb-Blyth, Sarah, Vanderwater, Catherine, Hartwick, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025814/
https://www.ncbi.nlm.nih.gov/pubmed/33799451
http://dx.doi.org/10.3390/curroncol28020115
_version_ 1783675561073180672
author Himelfarb-Blyth, Sarah
Vanderwater, Catherine
Hartwick, Julia
author_facet Himelfarb-Blyth, Sarah
Vanderwater, Catherine
Hartwick, Julia
author_sort Himelfarb-Blyth, Sarah
collection PubMed
description Tobacco cessation has been recognized as an important goal for all ambulatory cancer centres to provide the best possible treatment outcomes and quality of life. However, cessation interventions are applied inconsistently in this setting, with less than one-half of tobacco users being offered evidence-based interventions. The ‘opt-in’ approach traditionally used in cessation, which targets patients who feel ready to quit, may limit the number of patients who are able to receive treatment, and evidence suggests that tobacco users quit at the same rate regardless of their perceived readiness. This paper reports the results of implementing a tobacco cessation framework utilizing the 3As and an ‘opt-out’ approach as a standard of cancer care at a Regional Cancer Centre. A comparison of data from 2017–2018 and 2018–2019 demonstrated an increase in the number of patients screened for tobacco use (76.9% to 90.1%, respectively), and in the number of accepted referrals to quit support (11.5% to 34.7%, respectively). The revised framework was effective at improving referral acceptance rates, despite tobacco use rates remaining stable among the two groups. This demonstrates that employing the ‘opt-out’ approach is a more effective strategy to connect patients with the smoking cessation supports required to optimize their cancer care.
format Online
Article
Text
id pubmed-8025814
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80258142021-04-08 Implementing a 3As and ‘Opt-Out’ Tobacco Cessation Framework in an Outpatient Oncology Setting Himelfarb-Blyth, Sarah Vanderwater, Catherine Hartwick, Julia Curr Oncol Article Tobacco cessation has been recognized as an important goal for all ambulatory cancer centres to provide the best possible treatment outcomes and quality of life. However, cessation interventions are applied inconsistently in this setting, with less than one-half of tobacco users being offered evidence-based interventions. The ‘opt-in’ approach traditionally used in cessation, which targets patients who feel ready to quit, may limit the number of patients who are able to receive treatment, and evidence suggests that tobacco users quit at the same rate regardless of their perceived readiness. This paper reports the results of implementing a tobacco cessation framework utilizing the 3As and an ‘opt-out’ approach as a standard of cancer care at a Regional Cancer Centre. A comparison of data from 2017–2018 and 2018–2019 demonstrated an increase in the number of patients screened for tobacco use (76.9% to 90.1%, respectively), and in the number of accepted referrals to quit support (11.5% to 34.7%, respectively). The revised framework was effective at improving referral acceptance rates, despite tobacco use rates remaining stable among the two groups. This demonstrates that employing the ‘opt-out’ approach is a more effective strategy to connect patients with the smoking cessation supports required to optimize their cancer care. MDPI 2021-03-14 /pmc/articles/PMC8025814/ /pubmed/33799451 http://dx.doi.org/10.3390/curroncol28020115 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Himelfarb-Blyth, Sarah
Vanderwater, Catherine
Hartwick, Julia
Implementing a 3As and ‘Opt-Out’ Tobacco Cessation Framework in an Outpatient Oncology Setting
title Implementing a 3As and ‘Opt-Out’ Tobacco Cessation Framework in an Outpatient Oncology Setting
title_full Implementing a 3As and ‘Opt-Out’ Tobacco Cessation Framework in an Outpatient Oncology Setting
title_fullStr Implementing a 3As and ‘Opt-Out’ Tobacco Cessation Framework in an Outpatient Oncology Setting
title_full_unstemmed Implementing a 3As and ‘Opt-Out’ Tobacco Cessation Framework in an Outpatient Oncology Setting
title_short Implementing a 3As and ‘Opt-Out’ Tobacco Cessation Framework in an Outpatient Oncology Setting
title_sort implementing a 3as and ‘opt-out’ tobacco cessation framework in an outpatient oncology setting
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025814/
https://www.ncbi.nlm.nih.gov/pubmed/33799451
http://dx.doi.org/10.3390/curroncol28020115
work_keys_str_mv AT himelfarbblythsarah implementinga3asandoptouttobaccocessationframeworkinanoutpatientoncologysetting
AT vanderwatercatherine implementinga3asandoptouttobaccocessationframeworkinanoutpatientoncologysetting
AT hartwickjulia implementinga3asandoptouttobaccocessationframeworkinanoutpatientoncologysetting